Latest Pneumococcal vaccine Stories
Scientists recently revealed that they plan to study the pneumococcal vaccines in older adults to determine if there’s a strong immune response due to a higher dosage of the vaccine.
Genetics has provided surprising insights into why vaccines used in both the UK and US to combat serious childhood infections can eventually fail.
Grant MacKenzie of the MRC Unit in The Gambia and colleagues describe in this week's PLoS Medicine how they set up a population-based surveillance system to assess the impact of pneumococcal conjugate vaccines (PCVs) on invasive pneumococcal disease (IPD) and radiological pneumonia in children in The Gambia.
Check-list for a healthy life: Quit smoking. Don't drink too much. Exercise regularly.
Vaccines against the primary cause of deaths from pneumonia in developing countries could save millions of lives and are highly cost-effective.
Vaccinating young children against pneumonia in turn will protect the entire community.